Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
Nicola Clementi, Carolina Scagnolari, Antonella D’Amore, et al.
Pharmacological Research (2020) Vol. 163, pp. 105255-105255
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
Amira Mohammed Ali, Hiroshi Kunugi
Molecules (2021) Vol. 26, Iss. 5, pp. 1232-1232
Open Access | Times Cited: 116
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
Liyan Yang, Zhonglei Wang
Biomedicines (2021) Vol. 9, Iss. 6, pp. 689-689
Open Access | Times Cited: 88
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review
Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3900-3900
Open Access | Times Cited: 61
Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches
Hossam M. Abdallah, Ali M. El-Halawany, Alaa Sirwi, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 213-213
Open Access | Times Cited: 57
Fine-tuning of p-coumaric acid synthesis to increase (2S)-naringenin production in yeast
Jiwei Mao, Marta Tous Mohedano, Jing Fu, et al.
Metabolic Engineering (2023) Vol. 79, pp. 192-202
Open Access | Times Cited: 26
Flavonoids derived from medicinal plants as a COVID‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2
Abhishek Gour, Diksha Manhas, Swarnendu Bag, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4258-4283
Open Access | Times Cited: 46
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Shenghua Gao, Tianguang Huang, Letian Song, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 581-599
Open Access | Times Cited: 44
Microbial cell factories for the production of flavonoids–barriers and opportunities
Hongbiao Li, Yunbin Lyv, Shenghu Zhou, et al.
Bioresource Technology (2022) Vol. 360, pp. 127538-127538
Closed Access | Times Cited: 33
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity
Junyu Yang, Yixuan Ma, Yan Liu, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2735-2735
Open Access | Times Cited: 19
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Aijia Wu, Kunyu Shi, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115923-115923
Closed Access | Times Cited: 17
Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview
Deborah Giordano, Angelo Facchiano, Virginia Carbone
Molecules (2023) Vol. 28, Iss. 6, pp. 2470-2470
Open Access | Times Cited: 16
Azadirachta Indica Phytoconstituents as Novel Inhibitors for Main Proteases of COVID-19: Molecular Dynamics and Simulation Study
Ubaida Hussain, Fatima Gillani, Laiba Gull, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 74-84
Closed Access
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve?
Sarah Cristina Gozzi-Silva, Franciane Mouradian Emidio Teixeira, Alberto José da Silva Duarte, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 39
Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2
Susana A. Llivisaca-Contreras, Jaime Naranjo-Morán, Andrea Pino-Acosta, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 4099-4099
Open Access | Times Cited: 37
Lysosomal calcium and autophagy
Diego L. Medina
International review of cell and molecular biology (2021), pp. 141-170
Closed Access | Times Cited: 34
TRP channels in COVID-19 disease: Potential targets for prevention and treatment
Sahar M. Jaffal, Manal A. Abbas
Chemico-Biological Interactions (2021) Vol. 345, pp. 109567-109567
Open Access | Times Cited: 32
Phytochemicals for the treatment of COVID-19
Erica Españo, Jiyeon Kim, Kiho Lee, et al.
The Journal of Microbiology (2021) Vol. 59, Iss. 11, pp. 959-977
Open Access | Times Cited: 32
Endothelial Cell Metabolism in Vascular Functions
Antonio Filippini, Luca Tamagnone, Alessio D’Alessio
Cancers (2022) Vol. 14, Iss. 8, pp. 1929-1929
Open Access | Times Cited: 23
An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight
Shoaib Shoaib, Mohammad Azam Ansari, Geetha Kandasamy, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 795-795
Open Access | Times Cited: 12
The Molecular Mechanisms and Therapeutic Potential of Cranberry, D-Mannose, and Flavonoids against Infectious Diseases: The Example of Urinary Tract Infections
Πέτρος Ιωάννου, Stella Baliou
Antibiotics (2024) Vol. 13, Iss. 7, pp. 593-593
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top